Program Code: SCF-DBI-PECMO-MCS-0011**
Operational Window: Advanced Heart Failure → ECMO Stabilization → Mechanical Support Decision → Transplantation or Recovery → Long-Term Follow-Up
Primary Objective: Preserve myocardial recovery potential, prevent irreversible end-organ injury, optimize transplant readiness, support ventricular assist device integration, and maximize long-term cardiovascular adaptation.
SECTION 11.1
CLINICAL POSITIONING
Traditional ECMO Heart Failure Model
Focuses on:
Survival
Hemodynamic support
Bridge-to-transplant
Mechanical support
SCF-DBI Heart Failure Model
ECMO is viewed as:
Cardiovascular Recovery Preservation Technology
used to preserve:
Myocardial intelligence
Endothelial intelligence
Neurocardiac adaptation
Recovery biology
Future therapeutic options
Core Principle
Every ECMO-supported patient should have an active recovery, transplantation, and regeneration pathway assessment.
SECTION 11.2
ADVANCED MECHANICAL SUPPORT COMMAND CENTER
Strategic Objective
Coordinate all ECMO-to-transplant and ECMO-to-VAD decision pathways.
Operational Domains
Myocardial recovery
End-organ recovery
Neurologic preservation
Endothelial recovery
Transplant readiness
Mechanical support readiness
Command Outputs
Recovery probability
Transplant readiness
VAD suitability
Regeneration potential
Long-term adaptation probability
Primary Output
Advanced Cardiac Support Intelligence Score (ACSIS)
SECTION 11.3
ECMO BRIDGE CLASSIFICATION SYSTEM
Bridge Type I
Bridge-to-Recovery
Characteristics:
Reversible cardiac dysfunction
High myocardial recovery potential
Bridge Type II
Bridge-to-Decision
Characteristics:
Recovery uncertainty
Ongoing evaluation
Bridge Type III
Bridge-to-Transplant
Characteristics:
Recovery unlikely
Transplant candidate
Bridge Type IV
Bridge-to-VAD
Characteristics:
Long-term support anticipated
Bridge Type V
Bridge-to-Regeneration
Characteristics:
Experimental regenerative strategies considered
RHENOVA integration pathway
SECTION 11.4
BRIDGE-TO-TRANSPLANT OPERATIONS MANUAL
Strategic Objective
Maintain physiologic stability while optimizing transplant readiness.
Preservation Domains
Neurologic preservation
Renal preservation
Hepatic preservation
Pulmonary preservation
Endothelial preservation
Monitoring Variables
ANMS
NCRS
EII
STRI
ORCI
Primary Output
Transplant Readiness Intelligence Score (TRIS)
SECTION 11.5
TRANSPLANT READINESS FRAMEWORK
Clinical Readiness
Stable ECMO support
Controlled infection risk
Organ preservation
Recovery sustainability
Neurologic Readiness
CAI >70
Stable neurologic assessment
Preserved developmental trajectory
End-Organ Readiness
Renal recovery maintained
Hepatic recovery maintained
Pulmonary adaptation maintained
Classification
Ready
TRIS >80
Near Ready
TRIS 60–79
Requires Optimization
TRIS <60
SECTION 11.6
PRIMARY GRAFT DYSFUNCTION ECMO RESCUE PROGRAM
Clinical Positioning
Primary graft dysfunction represents:
Acute Allograft Adaptation Failure
Strategic Objectives
Preserve graft viability
Preserve end-organ function
Prevent secondary injury
Promote graft recovery
Monitoring Domains
Ventricular function
Lactate clearance
Perfusion adequacy
EII
NCRS
Primary Output
Graft Recovery Intelligence Score (GRIS)
SECTION 11.7
BRIDGE-TO-VAD CLINICAL FRAMEWORK
Strategic Objective
Identify patients requiring durable mechanical support.
Assessment Domains
Recovery potential
Transplant candidacy
Neurologic status
Organ recovery
Family readiness
Monitoring Variables
ACSIS
ANMS
CRIS
ORCI
Primary Output
VAD Readiness Intelligence Score (VRIS)
SECTION 11.8
PEDIATRIC HEART FAILURE ECMO INTEGRATION PLATFORM
Clinical Positioning
Heart failure is viewed as:
Progressive Neurocardiac Adaptation Failure
Surveillance Domains
Ventricular reserve
Perfusion reserve
Endothelial reserve
Recovery reserve
Monitoring Variables
Echocardiography
BNP/NT-proBNP
Lactate
NCRS
ANMS
Primary Output
Heart Failure Recovery Potential Score (HFRPS)
SECTION 11.9
RHENOVA CARDIAC REGENERATION & RECOVERY ARCHITECTURE
Strategic Goal
Identify and preserve myocardial recovery pathways.
Regeneration Domains
Domain 1
Cardiomyocyte Recovery
Domain 2
Microvascular Recovery
Domain 3
Endothelial Regeneration
Domain 4
Neurocardiac Recovery
Domain 5
Functional Cardiac Recovery
Monitoring Outputs
MRPS
HFRPS
GRIS
CRIS
SECTION 11.10
ECMO TRANSPLANT SURVEILLANCE PROGRAM
Strategic Objective
Continuously evaluate transplant candidacy.
Monitoring Domains
Organ recovery
Neurologic recovery
Infection risk
Immune competence
Recovery progression
Daily Outputs
TRIS
ACSIS
ORCI
SECTION 11.11
MECHANICAL SUPPORT ESCALATION FRAMEWORK
Level 1
Enhanced Monitoring
Triggers:
Reduced recovery velocity
HFRPS decline >10%
Level 2
Focused Mechanical Support Review
Triggers:
Persistent severe ventricular dysfunction
ACSIS decline >10%
Level 3
Multidisciplinary Advanced Heart Failure Review
Triggers:
Failure of recovery trajectory
Progressive end-organ burden
Level 4
VAD Activation Consideration
Triggers:
Recovery unlikely
TRIS inadequate
VRIS favorable
Level 5
Transplant Rescue Activation
Triggers:
Progressive instability
ANMS <50
Severe adaptation failure
SECTION 11.12
POST-TRANSPLANT ECMO RECOVERY PATHWAY
Phase I
Graft Stabilization
Objectives:
Optimize graft function
Preserve perfusion
Phase II
Recovery Preservation
Objectives:
Endothelial recovery
Immune recovery
Functional recovery
Phase III
Long-Term Adaptation
Objectives:
Graft resilience
Developmental preservation
Quality-of-life optimization
SECTION 11.13
LONGITUDINAL MECHANICAL SUPPORT SURVEILLANCE
Monitoring Timeline
ECMO Initiation
↓
VAD Implantation or Transplantation
↓
ICU Discharge
↓
Hospital Discharge
↓
30 Days
↓
90 Days
↓
6 Months
↓
12 Months
↓
Annual Surveillance
Surveillance Domains
Survival
Recovery
Neurodevelopment
Exercise capacity
Educational participation
Quality of life
SECTION 11.14
ECMO TRANSPLANT & VAD ANALYTICS PROGRAM
Strategic Objective
Evaluate outcomes across all advanced heart failure pathways.
Outcome Domains
Recovery success
VAD success
Transplant success
Neurodevelopmental outcomes
Functional outcomes
Primary Output
Advanced Cardiac Outcome Intelligence Score (ACOIS)
SECTION 11.15
TRANSPLANT & MECHANICAL SUPPORT SUCCESS ENDPOINTS
Clinical
Successful transplant
Successful VAD transition
Preserved organ function
Reduced complications
Recovery
Improved rehabilitation participation
Improved developmental outcomes
Improved quality of life
Biological Intelligence
ACSIS >80
TRIS >80
VRIS >80
HFRPS >80
GRIS >80
CRIS >80
Sustained cardiovascular adaptation
PAGE 11 COMPLETION
Next Page (Page 12):